Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Mycophenolic acid
Drug ID BADD_D01508
Description Mycophenolic acid is an an immunosuppresant drug and potent anti-proliferative, and can be used in place of the older anti-proliferative azathioprine. It is usually used as part of triple therapy including a calcineurin inhibitor (ciclosporin or tacrolimus) and prednisolone. It is also useful in research for the selection of animal cells that express the E. coli gene coding for XGPRT (xanthine guanine phosphoribosyltransferase).
Indications and Usage For the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids.
Marketing Status Prescription; Discontinued
ATC Code L04AA06
DrugBank ID DB01024
KEGG ID D05096
MeSH ID D009173
PubChem ID 446541
TTD Drug ID D04FBR
NDC Product Code 70518-3218; 60429-016; 72322-1049; 68084-918; 0904-6785; 60505-2965; 68254-5001; 68254-5002; 0078-0385; 70748-218; 70518-3255; 68084-907; 0904-6786; 24979-160; 50268-559; 51187-0004; 0378-4201; 60505-2966; 67877-426; 52076-6215; 0378-4202; 16729-261; 67877-427; 16729-189; 72322-1048; 70436-172; 60429-017; 24979-161; 20076-0405; 0078-0386; 70436-173; 57885-0009; 65727-011; 70748-217
Synonyms Mycophenolic Acid | Mycophenolate Mofetil | Mofetil, Mycophenolate | Mycophenolic Acid Morpholinoethyl Ester | Cellcept | Mycophenolate Sodium | Sodium Mycophenolate | Mycophenolate, Sodium | Myfortic | Mycophenolate Mofetil Hydrochloride | Mofetil Hydrochloride, Mycophenolate | RS 61443 | RS-61443 | RS61443
Chemical Information
Molecular Formula C17H20O6
CAS Registry Number 24280-93-1
SMILES CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Fungaemia11.01.11.002--
Fungal infection11.03.05.001--Not Available
Fungal skin infection23.09.02.001; 11.03.05.002--Not Available
Gait disturbance17.02.05.016; 08.01.02.0020.002895%
Gamma-glutamyltransferase increased13.03.01.011--
Gastric ulcer07.04.03.002--
Gastritis07.08.02.0010.001158%
Gastrooesophageal reflux disease07.02.02.0030.002316%
Gastroenteritis11.01.07.004; 07.19.03.0010.001158%Not Available
Gastrointestinal candidiasis11.03.03.011; 07.19.02.003--Not Available
Gastrointestinal disorder07.11.01.0010.001737%Not Available
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Gastrointestinal pain07.01.05.005--
Generalised oedema14.05.06.007; 08.01.07.004--
Gingival hyperplasia07.09.03.002--Not Available
Gingivitis11.01.04.013; 07.09.03.003--
Glaucoma06.03.01.0020.001158%
Gout15.01.06.001; 14.09.01.001--Not Available
Haematochezia24.07.02.012; 07.12.02.0030.001158%Not Available
Haematuria24.07.01.047; 20.02.01.006--
Haemoglobin13.01.05.018--Not Available
Haemoglobin decreased13.01.05.003--Not Available
Haemoglobin increased13.01.05.0040.001158%
Haemolytic uraemic syndrome20.01.03.011; 01.06.02.0010.001158%
Haemoptysis24.07.01.006; 22.02.03.004; 02.01.02.0060.001158%Not Available
Hallucination19.10.02.002--
Headache17.14.01.001--
Hemiparesis17.01.04.001--
Hepatitis09.01.07.0040.001158%Not Available
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 17 Pages